These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 28397717

  • 1. Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy.
    Xu NX, Xie QH, Sun ZX, Wang J, Li Y, Wang L, Liu SJ, Xue J, Hao CM.
    Chin Med J (Engl); 2017 Apr 20; 130(8):892-898. PubMed ID: 28397717
    [Abstract] [Full Text] [Related]

  • 2. Response to immunosuppressive therapy in PLA2R- associated and non-PLA2R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study.
    Wang J, Xie Q, Sun Z, Xu N, Li Y, Wang L, Liu S, Xue J, Hao CM.
    BMC Nephrol; 2017 Jul 10; 18(1):227. PubMed ID: 28693446
    [Abstract] [Full Text] [Related]

  • 3. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z, Dong W, Li Z, Chen Y, Song L, Li R, Wu Y, Fu L, Liang H, Tao Y, Xie J, Wang W, Liu S, Ye Z, Shi W, Liang X.
    Nephrology (Carlton); 2020 Mar 10; 25(3):219-229. PubMed ID: 31900967
    [Abstract] [Full Text] [Related]

  • 4. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.
    Zhang Q, Liu X, Zhang Z, Wu M, Huang B, Zhang Y, Liu B, Qi Z, Shan W, Wang L, Hu Z, Sun Z.
    Medicine (Baltimore); 2019 Nov 10; 98(45):e17658. PubMed ID: 31702617
    [Abstract] [Full Text] [Related]

  • 5. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D, Zou J, Zhang C, Zhang W, Lin F, Jiang G.
    Med Sci Monit; 2018 Jul 22; 24():5076-5083. PubMed ID: 30032157
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C, Li H, Wen YB, Li JN, Lin WF, Cai JF, Duan L, Li Y, Li XM, Li XW.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):544-551. PubMed ID: 28877834
    [Abstract] [Full Text] [Related]

  • 7. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X, Wen S, Zhu X, Yuan S, Xu X, Yang D, Sun L, Liu H, Liu F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr 28; 42(4):395-399. PubMed ID: 28490696
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A, Pieruzzi F, Trezzi B, Ghiggeri G, Napodano P, D'Amico M, Stellato T, Brugnano R, Ravera F, Rolla D, Pesce G, Giovenzana ME, Londrino F, Cantaluppi V, Pregnolato F, Volpi A, Rombolà G, Moroni G, Ortisi G, Sinico RA.
    J Nephrol; 2018 Apr 28; 31(2):271-278. PubMed ID: 29081027
    [Abstract] [Full Text] [Related]

  • 9. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L.
    Ren Fail; 2022 Dec 28; 44(1):428-433. PubMed ID: 35272568
    [Abstract] [Full Text] [Related]

  • 10. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA.
    Autoimmun Rev; 2016 Feb 28; 15(2):146-54. PubMed ID: 26527329
    [Abstract] [Full Text] [Related]

  • 11. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
    Guo N, Cao Y, Dai H, Yuan L, Shi L, Zhang Y.
    Med Sci Monit; 2019 Dec 09; 25():9364-9368. PubMed ID: 31813930
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of efficacy and safety of immunosuppressive therapy and rituximab targeting therapy in idiopathic membranous nephropathy].
    Zhao R, Fan R, Pan Y, Guo Y, Han Y, Wang Y, Zhang J, Yang H, Yu D, Chen W.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jul 09; 40(7):636-641. PubMed ID: 39179407
    [Abstract] [Full Text] [Related]

  • 13. [Expression of renal PLA2R in patients with idiopathic membranous nephropathy and its relationship with the curative effect of immunotherapy].
    Wang LJ, Shang MH, Zhuge YF, Huang YX, Rong S, Tang ZH, Bao JF, Yu Q, Yuan WJ.
    Zhonghua Yi Xue Za Zhi; 2016 Jan 05; 96(1):4-8. PubMed ID: 26792599
    [Abstract] [Full Text] [Related]

  • 14. M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy.
    Kanda S, Horita S, Yanagihara T, Shimizu A, Hattori M.
    Pediatr Nephrol; 2017 Apr 05; 32(4):713-717. PubMed ID: 27921164
    [Abstract] [Full Text] [Related]

  • 15. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
    Xiao C, Liu Y, Zhang X, Luo L, Li X, Wang T, Tian Z, Qin X, Liu J.
    J Clin Lab Anal; 2020 Sep 05; 34(9):e23368. PubMed ID: 32449206
    [Abstract] [Full Text] [Related]

  • 16. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
    Lin W, Li H, Li X, Qin Y, Su Y, Yu Y, Guan Y, Duan L, Li Y, Wen Y, Li X.
    Zhonghua Nei Ke Za Zhi; 2015 Sep 05; 54(9):783-8. PubMed ID: 26674797
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R, Wu Y, Zheng B, Zhang X, An D, Guo N, Wang J, Guo Y, Tang L.
    Sci Rep; 2021 Sep 15; 11(1):18407. PubMed ID: 34526634
    [Abstract] [Full Text] [Related]

  • 18. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA, McRae JL, Dwyer KM.
    Nephrology (Carlton); 2016 May 15; 21(5):397-403. PubMed ID: 26369693
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V.
    Nephrology (Carlton); 2015 Aug 15; 20(8):572-5. PubMed ID: 26194981
    [Abstract] [Full Text] [Related]

  • 20. Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy.
    Yeter HH, Isik Gonul I, Eraslan E, Karacalik C, Ogut B, Guz G.
    Clin Exp Nephrol; 2021 May 15; 25(5):488-500. PubMed ID: 33459908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.